In this final installment of our three-part conversation around psychedelic facilitation, we discuss the risks and benefits of a facilitator dosing alongside those they support. It is a controversial subject that will surely gain more traction as we collectively mature as psychedelic practitioners and explorers.
The podcast Psilocybin Says is embedded on this page from an open RSS feed. All files, descriptions, artwork and other metadata from the RSS-feed is the property of the podcast owner and not affiliated with or validated by Podplay.